Jacob Glanville
Founder, CEO & President at Centivax
San Francisco, California, United States
Summary
👤
Senior🎓
Top SchoolJacob Glanville is a serial biotechnology entrepreneur and computational immunoengineer with nine years of leadership building therapeutics-focused startups from discovery to pandemic response. As founder and CEO of Centivax and co-founder/CEO of Distributed Bio, he has pioneered computational antibody and vaccine platforms that accelerate monoclonal discovery, epitope focusing, and universal antivenom development. His background spans industry R&D at Pfizer and a PhD in Computational and Systems Immunology from Stanford, combining deep immunology expertise with practical productization of high-throughput bioengineering. Based in San Francisco, he is known for translating large-scale sequencing and computational design into clinically relevant biotherapeutics and for driving platforms that can recover hundreds of human-grade hits in weeks—a capability that reshapes antibody discovery timelines.
9 years of coding experience
12 years of employment as a software developer
Bachelor's degree MCB Genetics Genomics and Development, Bachelor's degree MCB Genetics Genomics and Development at University of California, BerkeleyPhD Computational and Systems Immunology, PhD Computational and Systems Immunology at Stanford University
Spanish, English, tzutujil, LatinGithub contributions (3)
immunoengineer/gliph
Mar 2017 - Dec 2020
Contributions:6 commits, 5 pushes, 1 branch in 3 years 9 months
hotspotsinteractions
immunoengineer/vdjdock
Dec 2020 - Dec 2020
Contributions:12 pushes, 1 branch in 4 days
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.